Resources with keywords: vaccines
COVAX is the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator. The ACT Accelerator is a ground-breaking global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines. COVAX is co-led by Gavi, the Coalition for Epidemic Preparedness Innovations (CEPI) and WHO. Its aim is to accelerate the development and manufacture of COVID-19 vaccines, and to guarantee fair and equitable access for every country in the world.
Manufacturing, safety and quality control of vaccines (Website, Infographic)This infographic explains the steps from completing the vaccine clinical trial phases through to distribution.
This article focuses on how vaccines work to protect our bodies from disease-carrying germs.
This article focuses on how vaccines work to protect our bodies from disease-carrying germs.
Gee J, Marquez P, Su J, et al.
A large observational, real-world study from Israel estimates that the Pfizer/BioNTech COVID-19 vaccine is 46% effective at preventing infection 14 to 20 days after the first dose and 92% 7 days after the second dose, backing the results of an earlier randomized, controlled trial.
Helpful info about the safety of vaccines, how to get a vaccine, the SARS-CoV-2 variants that are causing concern, etc.
